Surface Oncology, Inc. Gains 18.14%
Fri, Sep 17, 2021 at 05:30 PM
Surface Oncology, Inc. (SURF:NASDAQ) shot up at $7.1, a gain of 18.1%. On Thu, Sep 16, 2021, SURF:NASDAQ hit a New 2-Week Intraday Low of $5.87. From Thu, Sep 02, 2021, the stock recorded 33.33% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Surface Oncology, Inc. (SURF:NASDAQ)
Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses.
Top 10 Gainers:
- Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ), 135.4%
- HLBZ (HLBZ:NASDAQ), 96.56%
- Priority Technology Holdings, Inc. (PRTH:NASDAQ), 47.23%
- Innate Pharma S.A. (IPHA:NASDAQ), 40.87%
- FORG (FORG:NYSE), 29.18%
- 9F Inc. (JFU:NASDAQ), 24.24%
- X Financial (XYF:NYSE), 21.52%
- LGHL (LGHL:NASDAQ), 20.18%
- OPTT (OPTT:NYSEMKT), 18.75%
- Surface Oncology, Inc. (SURF:NASDAQ), 18.14%